Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
4basebio Plc | 4BB | 3. mai 2024 | 1 096.00 | +0.09 |
Avacta Group Plc | AVCT | 3. mai 2024 | 45.12 | -2.97 |
Bioventix Plc | BVXP | 3. mai 2024 | 4 325.00 | -0.12 |
C4X Discovery Holdings plc | C4XD | 3. mai 2024 | 9.75 | 0.00 |
Destiny Pharma | DEST | 3. mai 2024 | 18.39 | 0.00 |
Diaceutics Plc | DXRX | 3. mai 2024 | 98.00 | -1.65 |
E-Therapeutics Plc | ETX | 3. mai 2024 | 9.25 | -3.65 |
Evgen Pharma Plc | EVG | 3. mai 2024 | 0.82 | 0.00 |
Fusion Antibodies Plc | FAB | 3. mai 2024 | 3.38 | -3.43 |
Futura Medical | FUM | 3. mai 2024 | 36.80 | +8.24 |
Hemogenyx Pharmaceuticals Plc | HEMO | 3. mai 2024 | 1.60 | +2.43 |
HUTCHMED (China) Limited | HCM | 3. mai 2024 | 310.00 | 0.00 |
Immupharma Plc | IMM | 3. mai 2024 | 2.00 | -3.29 |
Ixico Plc | IXI | 3. mai 2024 | 8.18 | +2.25 |
NetScientific plc | NSCI | 3. mai 2024 | 61.80 | +0.64 |
Nuformix plc | NFX | 3. mai 2024 | 0.18 | -1.65 |
Oncimmune Holdings plc | ONC | 3. mai 2024 | 25.40 | +1.12 |
OptiBiotix Health plc | OPTI | 3. mai 2024 | 18.11 | +1.69 |
Ovoca Bio Plc | OVB | 3. mai 2024 | 0.79 | 0.00 |
Oxford BioDynamics plc | OBD | 3. mai 2024 | 8.00 | -1.23 |
Oxford Biomedica | OXB | 3. mai 2024 | 324.84 | +8.88 |
Physiomics | PYC | 3. mai 2024 | 1.23 | -12.07 |
PureTech Health Plc | PRTC | 3. mai 2024 | 222.97 | +3.98 |
Redx Pharma Plc | REDX | 3. mai 2024 | 16.00 | 0.00 |
Reneuron Group | RENE | 3. mai 2024 | 3.27 | 0.00 |
Sareum Holdings Plc | SAR | 3. mai 2024 | 24.25 | -3.39 |
Scancell Hldgs Plc | SCLP | 3. mai 2024 | 9.15 | -0.76 |
SkinBioTherapeutics Plc | SBTX | 3. mai 2024 | 9.02 | +0.20 |
Synairgen | SNG | 3. mai 2024 | 6.20 | -1.74 |
Tissue Regenix Group Plc | TRX | 3. mai 2024 | 61.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.